Literature DB >> 20620528

Copeptin in heart transplant recipients depends on kidney function and intraventricular septal thickness.

P Przybylowski1, J Malyszko, J S Malyszko.   

Abstract

Copeptin is cosynthesized with vasopressin, also known as antidiuretic hormone, with plasma levels similar to vasopressin. In the past 2 years, copeptin has been studied as a diagnostic and prognostic marker in infections and other diseases. In patients with destabilized heart failure, copeptin is an accurate prognostic marker for mortality. The aim of this study was to assess copeptin in orthotopic heart recipients in relation to New York Heart Association class and kidney function. The studies were performed on 139 prevalent patients after orthotopic heart transplantation-(OHT) including 105 males and 34 females. Glomerular filtration rate (GFR) was estimated using simplified Modification of Diet in Renal Disease (MDRD), Cockcroft-Gault, and new the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. In addition 24-hour creatinine clearances were performed on each patient. Complete blood count, urea, serum lipids, fasting glucose, creatinine, BNP were studied by standard laboratory method in the hospital central laboratory. Plasma copeptin was measured using a commercially available kit. Copeptin correlated with parameters of kidney function: creatinine (r = .39, P < .001), estimated GFR by MDRD (r = -.24, P < .01), estimated GFR by CKD-EPI (r = -.25, P < .01), creatinine clearance by Cockcroft-Gault (r = -.27, P < .01), 24-hour creatinine clearance (r = -.21, P < .05), cystatin C (r = .45, P < .001), and high-density lipoprotein (r = .18, P < .05), BNP (r = .25, P < .01), intraventricular septal diameter/thickness (IVS); r = -.30, P < .01), ejection fraction (r = -.17, P < .05), ferritin (r = .21, P < .05). Upon multiple regression analysis, predictors of copeptin were cystatin C and IVS, which explained 51% of copeptin variations (F = 3.21, P < .03 and Standard error of estimate was 0.57). Beta value for cystatin C was 0.51 (P = .024) and for IVS was -0.59 (P = .018). Copeptin in a heart transplant population was independently associated with kidney function and IVS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620528     DOI: 10.1016/j.transproceed.2010.03.138

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Akiko Nakajima; Yan Lu; Haruna Kawano; Shigeo Horie; Satoru Muto
Journal:  Clin Exp Nephrol       Date:  2015-02-27       Impact factor: 2.801

2.  Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients.

Authors:  Debbie Zittema; Else van den Berg; Esther Meijer; Wendy E Boertien; Anneke C Muller Kobold; Casper F M Franssen; Paul E de Jong; Stephan J L Bakker; Gerjan Navis; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

3.  Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.

Authors:  Annarein J C Kerbert; Len Verbeke; Fang W T Chiang; Wim Laleman; Johan J van der Reijden; Wim van Duijn; Frederik Nevens; Ron Wolterbeek; Bart van Hoek; Hein W Verspaget; Minneke J Coenraad
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

4.  Modern peptide biomarkers and echocardiography in cardiac healthy haemodialysis patients.

Authors:  Franz Maximilian Rasche; Stephan Stoebe; Thomas Ebert; Silvana Feige; Andreas Hagendorff; Wilma Gertrud Rasche; Filip Barinka; Volker Busch; Ulrich Sack; Jochen G Schneider; Stephan Schiekofer
Journal:  BMC Nephrol       Date:  2017-05-30       Impact factor: 2.388

5.  Is copeptin a reliable biomarker of primary monosymptomatic nocturnal enuresis?

Authors:  Hanna Szymanik-Grzelak; Maria Urszula Daniel; Piotr Skrzypczyk; Iwona Kotuła; Małgorzata Pańczyk-Tomaszewska
Journal:  Cent Eur J Immunol       Date:  2019-04-15       Impact factor: 2.085

6.  Serum copeptin levels in adolescents with primary hypertension.

Authors:  Edyta Tenderenda-Banasiuk; Anna Wasilewska; Renata Filonowicz; Urszula Jakubowska; Marlena Waszkiewicz-Stojda
Journal:  Pediatr Nephrol       Date:  2013-12-29       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.